Kang Min-Ji, Lee Kyeong-Ryoon, Choi You-Jin, Chae Yoon-Jee
College of Pharmacy, Woosuk University, Wanju, Republic of Korea.
Laboratory Animal Resource Center, Korea Research Institute of Bioscience and Biotechnology, Cheongju, Republic of Korea.
Nat Prod Res. 2024 Nov 5:1-9. doi: 10.1080/14786419.2024.2420333.
Multidrug resistance is a crucial factor contributing to the failure of cancer treatment. Multidrug resistance protein 1 (MDR1) is the most relevant efflux transporter associated with multidrug resistance. The objective of this study was to identify potent MDR1 inhibitors from flavonols. Fifteen flavonols were identified as inhibitors of MDR1 , with four compounds exhibiting strong inhibitory activity, having IC values below 5 μM. These potent MDR1 inhibitors were found to enhance chemosensitivity to doxorubicin in MDR1-overexpressing cells. The results of the multiple-factor analysis indicated that the 3, 5, and 6-methoxy groups were crucial for enhancing the inhibitory effects on MDR1. Furthermore, the total number of methoxy groups in the flavonol backbone was found to be a significant factor in determining the potency of MDR1 inhibition. These observations provide fundamental insights into the structure-activity relationship between flavonol derivatives and MDR1 inhibition, potentially aiding in overcoming drug resistance in cancer.
多药耐药性是导致癌症治疗失败的关键因素。多药耐药蛋白1(MDR1)是与多药耐药性最相关的外排转运蛋白。本研究的目的是从黄酮醇中鉴定出有效的MDR1抑制剂。15种黄酮醇被鉴定为MDR1抑制剂,其中4种化合物表现出强抑制活性,IC值低于5μM。这些有效的MDR1抑制剂被发现可增强对过表达MDR1的细胞中阿霉素的化疗敏感性。多因素分析结果表明,3、5和6位甲氧基对于增强对MDR1的抑制作用至关重要。此外,发现黄酮醇主链中甲氧基的总数是决定MDR1抑制效力的重要因素。这些观察结果为黄酮醇衍生物与MDR1抑制之间的构效关系提供了基本见解,可能有助于克服癌症中的耐药性。